EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis

Ellen Hollands Steffensen iD, Lars Henning Pedersen iD, Stina Lou, Ida Vogel, Danish Cytogenetic Central Registry Study Group

Acta Obstetricia et Gynecologica Scandinavica · 2023

DOI: 10.1111/aogs.14573 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2023. Written by Ellen Hollands Steffensen and 4 co-authors. Institution: Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark. Major MEDLINE topics: Down Syndrome, Prenatal Diagnosis. Cited 2 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Aarhus University, Faculty of Health, Health Research Fund of Central Denmark Region, Helsefonden.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevalence of congenital malformations, and early childhood morbidity of children with Down syndrome before and after implementation of this screening program. Material and methods A nationwide register‐based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biometry, prevalence of congenital malformations, and early childhood morbidity related to the implementation of a national prenatal screening program.

Results

We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z‐scores of birthweight and head circumference increased over time before screening, but this temporal development changed after implementation by −0.05 (95% confidence interval [CI]: −0.11 to 0.01) and −0.05 (95% CI −0.12 to 0.02), respectively. Just after implementation, the prevalence of non‐severe congenital heart disease decreased (relative change in odds 0.48 [95% CI: 0.24–0.94]). For severe congenital heart disease, atrioventricular septal defect, and non‐heart malformations, this change was 1.16 (95% CI: 0.56–2.41), 0.95 (95% CI: 0.43–2.03), and 0.98 (95% CI: 0.33–2.76), respectively. For all malformations, pre‐existing temporal developments did not change following implementation of screening. The implementation was associated with higher odds of admission to a neonatal intensive care unit (relative change 1.98 [95% CI: 0.76–5.26]) and an increased risk of hearing impairment (risk difference 3.4% [95% CI: −0.4% to 7.1%]). In contrast, the implementation was not associated with the incidence of hospital admissions by 2 years of age or with the probability of a thyroid disorder.

Conclusions

After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non‐severe congenital heart disease; this result is, however, limited by small numbers.

Subjects

MeSH terms (MEDLINE)

Down SyndromePrenatal DiagnosisHumansMaleFemalePregnancyInfant, NewbornAdultDenmarkInterrupted Time Series AnalysisProgram EvaluationHeart Defects, Congenital

Author keywords

anthropometrycongenital abnormalitiescongenital heart defectfirst-trimester combined screeninginterrupted time series analysisphenotypeprenatal ultrasonographytrisomy 21

Authors and institutions

  • Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • DEFACTUM - Public Health & Health Services Research, Central Denmark Region, Aarhus, Denmark.

ORCID profiles: Ellen Hollands Steffensen, Lars Henning Pedersen

Funding

  • Aarhus University, Faculty of Health
  • Health Research Fund of Central Denmark Region
  • Helsefonden
  • Novo Nordisk Fonden
  • Aarhus Universitet

Cite

APA

Steffensen, E. H., Pedersen, L. H., Lou, S., Vogel, I., & Danish Cytogenetic Central Registry Study Group (2023). Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14573

Vancouver

Steffensen EH, Pedersen LH, Lou S, Vogel I, Danish Cytogenetic Central Registry Study Group. Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14573

BibTeX
@article{Steffensen2023,
  author = {Steffensen, Ellen Hollands and Pedersen, Lars Henning and Lou, Stina and Vogel, Ida and Danish Cytogenetic Central Registry Study Group, Danish Cytogenetic Central Registry Study Group},
  title = {Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  doi = {10.1111/aogs.14573}
}
Start for free →